Gladstone in the News
October 2, 2020
Clinical Omics—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains his lab's recent discovery of the the gene networks that distinguish regulatory T cells from other types of T cells, and the implication for therapies against cancer and autoimmune diseases.
Gladstone Experts
Autoimmune Diseases
Marson Lab
Gladstone in the News
October 1, 2020
Technology Network—Senior Investigator Bruce Conklin, MD, explains how SARS-CoV-2 damages heart cells and how heart cells grown in the lab could be used to screen for drugs against infection by the novel coronavirus.
Gladstone Experts
COVID-19
Cardiovascular Disease
Conklin Lab
Gladstone in the News
October 1, 2020
Genetic Engineering and Biotechnology News—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains the implications of his lab's recent identification of gene networks that control the function of immune cells, known as regulatory T cells, for therapies against cancer and autoimmune diseases.
Gladstone Experts
Autoimmune Diseases
Genomic Immunology
Marson Lab
Article
September 30, 2020
The findings help point toward drug targets for new immune therapies to treat cancer and autoimmune disease
Genomic Immunology
Marson Lab
Gladstone in the News
September 30, 2020
San Francisco Chronicle—Warner Greene, MD, PhD, director of the Center for HIV Cure Research, explains how Timothy Ray Brown, who was cured of HIV/AIDS via a bone marrow transplant, changed the field of HIV research.
Gladstone Experts
HIV/AIDS
Center for HIV Cure Research
Greene Lab
Video
September 30, 2020
Learn how your institution can have a profound impact on traditionally underrepresented people working in the field—while pushing innovation further than ever before.
Gladstone Experts
Diversity
Gladstone in the News
September 28, 2020
heart.org News—A study of U.S. veterans identified 14 genes that may predict the risk of abdominal aortic aneurysm.
Tcheandjieu Lab
Gladstone in the News
September 26, 2020
Life Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Krogan Lab
Ott Lab
CRISPR/Gene Editing